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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the benefits and harms of community-based exercise and physical activity programmes led by non-healthcare exercise profes-
sionals for osteoarthritis, compared to those delivered by healthcare professionals, self-directed interventions, home-based programmes
or continued general practitioner (GP) care.
B A C K G R O U N D
Osteoarthritis (OA) is predicted to become the 4th leading cause
of worldwide disability by 2020 as the population ages, and people
become heavier and less active (Woolf 2003). The World Health
Organisation estimates that approximately 10% of the population
over 60 years old may experience pain and functional limitation
associated with OA (Cooper 2013) . At an individual level almost
three quarters of people with OA live in constant pain. One third
either have to give up work or reduce their working hours; and
one third report emotional distress. Forty per cent of people with
OA report that their current treatment is either not very effective
or totally ineffective (Arthritis Care 2012). This is a social and
economic burden that is poorly managed and is unsustainable
within the present healthcare system.
Evidence-based guidelines recommend exercise and physical activ-
ity as a core modality for OA to reduce pain and increase function
(NICE 2014; Fernandes 2013). A variety of definitions exist for
exercise and physical activity. For the purpose of this review wewill
use the definition provided by the UKDepartment of Health: “all
forms of activity, such as everyday walking or cycling to get from
A to B, active play, work-related activity, active recreation (such
as working out in a gym), dancing, gardening or playing active
games, as well as organised and competitive sport” (Department
of Health 2011).
Healthcare professionals are ideally placed and appropriately
skilled to provide this advice, but timely access to health services
is a growing problem in the face of increasing referrals and lim-
ited resources (Salisbury 2013). As such, a strategic health care
and public health approach to long-term management of OA is
required to ensure people receive timely access to effective inter-
ventions and activities. Current lack of access may contribute to
the problem of almost half of people with OA reporting they do
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no exercise or physical activity to help their condition (Arthritis
Care 2012).
Cochrane reviews evaluating the effectiveness of land- and water-
based exercise interventions for OA conclude that short-term im-
provements in pain and function are gained (Bartels 2007; Fransen
2014; Fransen 2015), particularly in the knee joint (Fransen
2015). The evidence for the effects on the hip joint are less con-
clusive, notably for functional improvements (Fransen 2014). Ev-
idence synthesis also suggests that in the short term, supervised
regimens effect greater benefit although home-based interventions
tend to result in greater adherence in the long-term (Ashworth
2005), although these outcomes are based on other chronic dis-
eases as no studies in OA met the inclusion criteria. The most ef-
fective means of enhancing adherence to exercise remains unclear;
nor is there a validated tool to reliably measure adherence (Jordan
2010). No evidence synthesis exists regarding the effectiveness of
exercise or physical activity led by community-based, non-health-
care professionals.
In recent years, community-based exercise and physical activity
delivered by non-healthcare professionals has gained prevalence,
as demands on primary and secondary care services are height-
ened. In particular, cardiac rehabilitation schemes that facilitate
the transition from hospital-based services to community and self-
management approaches have achieved success using appropriately
trained and accredited leisure-based exercise facilitators (Anderson
2016) - a model which may be suitable for other pathologies. Cur-
rently, therapeutic exercise provision for OA is generally managed
within the health service. Exercise Referral Schemes (ERS) located
within leisure centres are available, but rarely evaluated to deter-
mine short or long-term efficacy (Sowden 2008). A recent review
of ERS for all pathologies (these included obesity, cardiovascular
disease, diabetes andmental health) andwhere referral came froma
healthcare professional, suggested inconclusive evidence regarding
clinical and cost-effectiveness in the short-term and no evidence
to support long-term changes to physical activity (Pavey 2011).
Although outcomes of community-based trials in OA are avail-
able, the effects of this type of intervention remain uncertain, and
an accumulation of the evidence would inform future service plan-
ning and provision.
Description of the condition
OA is the most common form of arthritis, normally affecting peo-
ple over the age of 45 (NICE 2014). Pathological changes can oc-
cur in any joint, but the knees, hips, hands and spine are predom-
inantly affected, resulting in pain, reduced mobility and loss of
function (Arthritis Research UK 2013). Pathophysiological char-
acteristics of OA include localised cartilage loss, periarticular re-
modelling of bone and local signs of connective tissue inflamma-
tion. Local muscle weakness and atrophy are also frequently ob-
served (Felson 2013; NICE 2014).
Currently there is no cure for OA, but management guidelines
suggest exercise and physical activity as a core modality to manage
symptoms and reduce the impact of the disease (NICE 2014;
Fernandes 2013).
Description of the intervention
Pain, functional disability and reduced muscle strength are cor-
related in OA, and as such the benefits of exercise and physical
activity interventions are recognised (Bijlsma 2011; Jan 2008).
Strengthening, mobilising and aerobic interventions are all rec-
ommended and induce benefits (Ashworth 2005; Bartels 2007;
Fransen 2015;NICE 2014), but evidence regarding frequency and
intensity is not conclusive. However, previous data suggest that de-
spite the strength of the recommendation for exercise, only 20% of
patients with OA reportedly receive physiotherapy and advice on
exercise (Arthritis Research Campaign 2002). Many people may
not be exercising at all, but equally others are likely to be seeking
advice from other ’exercise professionals’ based in the community
providing a variety of exercise and physical interventions for peo-
ple with OA. An evidence synthesis regarding the effectiveness of
these types of interventions is currently unavailable.
How the intervention might work
Exercise and physical activity can increase health status, modify
disease activity, reduce disability, improve function and enhance
sense of well-being in patients with lower limbOA (Bennell 2005;
Pelland 2004). From a biomedical perspective the disease pro-
cess in OA may be a result of, or contribute to, muscle weakness
and sensorimotor dysfunction resulting in further biomechanical
stress around the joints (Hurley 1999). Exercise can strengthen
muscle and therefore positively influence associated pain and re-
duced function (Bennell 2005). Furthermore, clinical symptoms
of OA can impact upon psychosocial factors such as health be-
liefs, self-efficacy and coping strategies; evidence suggests that ex-
ercise can have a positive effect on these traits through provision
of an active coping strategy (Hurley 2013). Traditionally, physical
interventions for OA are delivered within a healthcare environ-
ment by physiotherapists following referral from primary or sec-
ondary care (NICE 2014). However, in other chronic conditions
such as cardiac and respiratory disease, provision of community-
based exercise in leisure centres or exercise facilities, delivered by
’exercise professionals’ is becoming increasingly prevalent (Pavey
2011). In some locations (e.g. UK, Australia, Scandinavia) indi-
viduals can receive subsidised exercise if referred from a healthcare
professional (Anderson 2016; Pavey 2011). In other areas where
referral schemes are not supported, access to publicly-available ex-
ercise provision, in leisure centres for example, is ubiquitous. We
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are currently unaware of the potential benefit or harm of commu-
nity-based, non-healthcare led exercise and physical activity inter-
ventions for people with OA.
Why it is important to do this review
Timely access to healthcare interventions is becoming a growing
issue in the face of an ageing population, increasing referrals and
limited resources (Salisbury 2013). Individuals with OA are ad-
vised to exercise and remain physically active, but physiotherapy
is only provided to the minority (Arthritis Research Campaign
2002). Alternative exercise providers may therefore have a role in
managing the vast population of people with OA who seek advice
on either self-managing their condition or continuing with exer-
cise and physical activity interventions post-discharge fromhealth-
care services (Pavey 2011). Although highly skilled and compe-
tent, these providers do not have traditional professional qualifi-
cations commensurate with healthcare provision (Department of
Health 2001). Therefore it is imperative that the effectiveness of
interventions delivered by such providers is established. If clinical
effectiveness is determined, greater consideration can be given to
models of care and appropriate providers of interventions through-
out the patient pathway.
This review will be conducted according to the guidelines recom-
mended by the Cochrane Musculoskeletal Group Editorial Board
(Ghogomu 2014).
O B J E C T I V E S
To assess the benefits and harms of community-based exercise
and physical activity programmes led by non-healthcare exercise
professionals for osteoarthritis, compared to those delivered by
healthcare professionals, self-directed interventions, home-based
programmes or continued general practitioner (GP) care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include (cluster) randomised controlled trials (RCTs) and
controlled clinical trials (CCTs) that use quasi-randomised meth-
ods of allocation, including cross-over designs. We will include
studies reported as full-text, those published as abstract only, and
unpublished data. There will be no language restriction.
Types of participants
We will include adults with a clinical or radiographic diagnosis of
lower limb osteoarthritis (OA) in accordance with internationally-
recognised diagnostic criteria (Altman 1986).
These criteria are as follows:
OA should be diagnosed clinically without investigation if a per-
son:
• is 45 or over; and
• has activity-related joint pain; and
• has no morning joint-related stiffness, or morning stiffness
that lasts no longer than 30 minutes.
Studies that diagnose according to radiographic evidence are also
eligible for inclusion (Altman 1986). The evidence suggesting ra-
diographic OA are as follows:
• non-uniform joint space loss;
• osteophyte formation;
• cyst formation;
• subchondral sclerosis.
We will exclude participants that do not meet the diagnostic cri-
teria.
Types of interventions
We will include trials comparing an exercise or physical activity
programme, delivered to groups or individuals in the community
and facilitated or supervised by a professional exercise provider
(exercise professional).
The definitions of each of these criteria are detailed below.
Professional exercise provider
Graduate in exercise-related discipline (e.g. sports science, sports
rehabilitation). Trained exercise instructor (e.g. Register of Exer-
cise Professionals (UK), European Register of Exercise Profession-
als (EU), Canadian Fitness Professionals, American Council on
Exercise (US), Fitness Professionals Association (Russia)). Special-
ist trained instructor (e.g. Tai Chi, Pilates).
To meet the definition of ’professional exercise provider’, the per-
son must not be a healthcare professional or a lay leader. Health-
care professionals are defined as those with a recognised profes-
sional qualification in medical or allied health professions (e.g.
physiotherapy, physical therapy, occupational therapy, nursing,
medicine, chiropractic, osteopathy).
Programmes
Physical activity or exercise-based programmes can include:
• Exercise on prescription schemes;
• Exercise classes (any strength, aerobic, flexibility, co-
ordination regimens);
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• Gym sessions;
• Water-based activities;
• Walking programmes;
• Cycling programmes;
• Tai chi/Pilates;
• Dancing;
• Gardening.
No restrictions will be applied on the duration or intensity of
interventions.
For reporting clarity, the Cochrane Musculoskeletal Group
(CMSG) classification criteria will be applied to interventions:
a. Static weight bearing (SWB); including single leg standing.
b. Dynamic weight bearing exercise low force (DWBLF); includ-
ing walking and Tai chi.
c. Dynamic weight bearing exercise high force (DWBHF); includ-
ing jogging, jumping, running, dancing and whole body vibration
platforms.
d. Non-weight bearing exercise low force (NWBLF); e.g. low load,
high repetition strength training.
e. Non-weight bearing exercise high force (NWBHF); e.g. pro-
gressive resisted strength training.
f. Combination (COMB); more than one of the above exercise
interventions.
Intervention settings
• Adult education centre;
• Community-based facility;
• Leisure centre/gymnasium;
• Village hall;
• University/college campus;
• Outside spaces;
• Home-based programmes that are supervised by an exercise
professional rather than self-directed domestic interventions.
To be included, the interventions must not be based in primary
or secondary health care.
Primary care is defined as health care provided in the community
by a healthcare practitioner or clinic. Secondary care is defined as
a specialist healthcare provider (e.g. hospital) where interventions
are provided following referral from another source (normally pri-
mary care).
Comparator interventions will include:
1. No intervention;
2. ’Sham’ intervention;
3. Continued general practitioner (GP) care;
4. Self-managed physical activity (i.e. self-initiated and
managed outside of any formal or organised group activity);
5. Lay-led interventions;
6. Health professional led interventions;
7. Healthcare-based classes or exercise sessions;
8. Physiotherapy;
9. Nurse-led interventions;
10. Self-management or education sessions.
Interventions that compare other interventions such as bracing or
medication will not be included, as the use of alternative deliverers
of exercise is of interest rather than other non-pharmacological
interventions.
Co-interventions that include education and self-management de-
livered by non-healthcare professionals will be eligible if they are
applied equally across all groups. Education and self-management
interventions can also be included as comparator interventions.
Important anticipated comparisons will include but will not be
limited to:
1. Interventions delivered by exercise professionals compared
to healthcare professionals;
2. Interventions delivered by exercise professionals compared
to self-management;
3. Interventions delivered by exercise professionals compared
to no intervention.
Types of outcome measures
Major outcomes
1. Pain with a hierarchy of 11 levels
• Pain overall
• Pain on walking
• KOOS/HOOS/WOMAC pain subscale
• Pain on activities other than walking
• KOOS/HOOS/WOMAC global scale
• Lequesne osteoarthritis index global score
• Other algofunctional scale
• Patient’s global assessment
• Physician’s global assessment
• Other outcome
• No continuous outcome reported
2. Physical function with a hierarchy of 8 levels
• Global disability score
• Walking disability
• KOOS/HOOS/WOMAC disability subscore
• Composite disability scores other than KOOS/HOOS/
WOMAC
• Disability other than walking
• KOOS/HOOS/WOMAC global scale
• Lequesne osteoarthritis index global score
• Other algofunctional scale
3. Quality of life
• Short Form (SF)-36, Mental Component Summary (MCS).
• SF-12 MCS.
• EuroQol.
• Other measures
4Community-based exercise and physical activity programmes led by exercise professionals for osteoarthritis (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
4. Number of participants experiencing any adverse or serious
adverse event
5. Number of participants who withdrew for any reason
6. Number of participants experiencing any serious adverse events
Minor outcomes
1. Attrition rates (as a proxy for acceptability - limitations of
this measure will be acknowledged)
2. Adherence (self-reported or direct measures)
3. Any data reporting cost-effectiveness, cost-benefit or cost-
utility
Search methods for identification of studies
Electronic searches
We will search the Cochrane Central Register of Controlled
Trials (CENTRAL), MEDLINE (Ovid), EMBASE (Ovid),
AMED (Ovid), PsycINFO (Ovid), CINAHL (NICE Health
Database Advanced Search), Science and Social Science Ci-
tation Index (Web of Science, ISI), SPORTDiscus (EB-
SCO), Ageline (EBSCO), Physiotherapy Effectiveness Database
PEDRO (www.pedro.org.au/), OTSeeker (www.otseeker.com/),
TRIPDatabase (www.tripdatabase.com/),Grey literature database
(www.OpenGrey.eu) and clinical trial registries (ClinicalTri-
als.gov (www.ClinicalTrials.gov) and the WHO trials portal
(www.who.int/ictrp/en/)).
We will search all databases from their inception to the present,
and we will impose no restriction on language of publication.
See Appendix 1 for the MEDLINE search strategy.
Searching other resources
We will check reference lists of all primary studies and review
articles for additional references.
We will search for errata or retractions from included studies pub-
lished in full-text on PubMed (www.ncbi.nlm.nih.gov/pubmed)
and report the date this was done within the review.
Data collection and analysis
Selection of studies
Review authors (OB, EH, JJ, NW) will independently screen for
inclusion the titles and abstracts of all the studies we identify as
a result of the search and code them as ’retrieve’ (eligible or po-
tentially eligible/unclear) or ’do not retrieve’. We will retrieve the
full-text study reports/publication and two review authors (EH,
NW) will independently screen the full-text and identify studies
for inclusion, and identify and record reasons for exclusion of the
ineligible studies. We will resolve any disagreement through dis-
cussion or, if required, we will consult a third person (OB, JJ). We
will identify and exclude duplicates and collate multiple reports of
the same study so that each study, rather than each report, is the
unit of interest in the review. We will record the selection process
in sufficient detail to complete a PRISMA flow diagram (Moher
2009) and ’Characteristics of excluded studies’ table.
Data extraction and management
We will use a data collection form for study characteristics and
outcome data, which has been piloted on at least one study in
the review. Two review authors (of OB, EH, JJ, NW) will extract
study characteristics from included studies. A third review author
will resolve any discrepancies between the two authors. We will
extract the following study characteristics:
1. Methods: study design, total duration of study, details of
any ’run in’ period, number of study centres and location, study
setting, withdrawals, and date of study.
2. Participants: N, mean age, age range, gender, disease
duration, severity of condition (based on self-report or diagnostic
criteria), diagnostic criteria, disease duration; inclusion criteria,
and exclusion criteria. When reported, other data such as
educational attainment and socio-economic status or place of
residence will be extracted.
3. Interventions: Description of the exercise intervention
including type, supervision (group or individual), duration,
intensity, provider (e.g. fitness instructor) and setting (e.g. leisure
centre). Description of the comparator, including type,
supervision, duration, intensity, provider and setting.
Description of any co-interventions
4. Outcomes: major and minor outcomes specified and
collected, and time points reported, including a description of
the measurement tool used for continuous outcomes (scale of
tool and direction of effect).
5. Characteristics of the design of the trial as outlined below in
the ’Assessment of risk of bias in included studies’ section.
6. Notes: funding for trial, and notable declarations of interest
of trial authors.
Two of the four review authors (OB, EH, JJ, NW) will indepen-
dently extract outcome data from included studies. The number
of events and number of participants per treatment group for di-
chotomous outcomes (e.g. adverse events) and means and stan-
dard deviations and number of participants per treatment group
for continuous outcomes (e.g. pain) will be extracted.Wewill note
in the ’Characteristics of included studies’ table if outcome data
were not reported in a usable way and when data were transformed
or estimated from a graph. We will resolve disagreements by con-
sensus or by involving a third person (JJ, OB). Two review authors
(OB, JJ) will transfer data into the Review Manager (RevMan
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2014) file.We will double-check that data are entered correctly by
comparing the data presented in the systematic review with the
study reports.
Any studies that report health economic data will be reviewed
and extracted by one author (JP). A second review author (NW)
will spot-check study characteristics for accuracy against the trial
report.
If both final values and change from baseline values are reported
for the same outcome, we will extract change from baseline values.
If both unadjusted and adjusted values for the same outcome are
reported, we will extract adjusted values. If both ITT analysis
and per-protocol analyses are reported, we will extract data based
on ITT analysis preferentially. However, it is envisaged that most
studies may not report ITT analysis, so per-protocol analysis data
will also be extracted. The same procedure will apply to outcomes
assessing benefits and outcomes assessing harms. Formultiple time
points reporting, we will extract data for all time points, but meta-
analysis will only be undertaken at the 6-month follow-up point to
reflect medium-term adherence. We anticipate that intervention
effects are likely to be highest immediately post-intervention, but
the longer-term benefits are of utmost importance as an indicator
of continued and sustained exercise.
Assessment of risk of bias in included studies
Two of the four review authors (OB, EH, JJ, NW) will indepen-
dently assess risk of bias for each study using the criteria outlined
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011a). We will resolve any disagreements by discussion
or by involving another author (OB, JJ). We will assess the risk of
bias according to the following domains:
1. Random sequence generation;
2. Allocation concealment;
3. Blinding of participants and personnel;
4. Blinding of outcome assessment. Blinding of self-report
(subjective) and objective outcomes will be reported separately;
5. Incomplete outcome data;
6. Selective outcome reporting;
7. Other bias (conflicting interests). Possible sources of bias
may include: inappropriate administration of an intervention (or
co-intervention); baseline imbalance between the groups,
treatment contamination, inappropriate analysis in cluster
designs.
We will grade each potential source of bias as high, low or unclear
risk, and provide a quote from the study report together with a
justification for our judgment in the ’Risk of bias’ table. We will
summarise the ’Risk of bias’ judgements across different studies for
each of the domains listed. We will consider blinding separately
for different key outcomes where necessary (e.g. for unblinded
outcome assessment, risk of bias for all-cause mortality may be
different than for a patient-reported pain scale). As well, we will
consider the impact of missing data by key outcomes.
Where information on risk of bias relates to unpublished data or
correspondence with a trialist, we will note this in the ’Risk of bias’
table.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
We will present the figures generated by the ’Risk of bias’ tool to
provide summary assessments of the risk of bias.
Risk of bias
Risk of bias will be assessed using the Cochrane ’Risk of bias’ tool
as described in theCochrane Handbook.
Sequence generation: ’Low risk’ of bias if a random component in
the sequence generationprocess is described (for example, referring
to a random number table). ’High risk’ of bias when the authors
describe a non-random component in the sequence generation
process (e.g. sequence is generated by hospital or clinic record
number). ’Unclear risk’ of bias if not specified in the paper.
Allocation concealment: ’Low risk’ of bias if the personnel allo-
cated to enrol participants could not foresee assignment, by using
an appropriate method used to conceal allocation (e.g. central allo-
cation including telephone, web-based and pharmacy-controlled
randomisation, sequentially-numbered, opaque, sealed envelopes.
’High risk’ of bias if concealment allocation was not guaranteed.
’Unclear risk’ of bias if not specified in the paper.
Blinding: We will describe for each included study the methods
used, if any, to blind study participants and personnel from knowl-
edge of which intervention a participant received. ’Low risk’ of bias
if the authors state explicitly that the primary outcome variables
were assessed blindly. ’High risk’ of bias if the outcomes were not
assessed blindly and this was likely to affect results. ’Unclear risk’
of bias if not specified in the paper.
Incomplete outcome data: ’Low risk’ of bias if there are no missing
data, or missing outcome data are balanced in numbers across
intervention groups, with similar reasons for that missing data
and unlikely to alter the results in the study. ’High risk’ of bias if
missing outcome data are likely to bias the results. ’Unclear risk’
of bias if not specified in the paper.
Selective reporting: ’Low risk’ of bias if there is no evidence that
outcomes were selectively reported (for example, all relevant out-
comes in the methods section are reported in the results section).
’High risk’ of bias if some important outcomes are subsequently
omitted from the results. ’Unclear risk’ of bias if not specified in
the paper.
Assesment of bias in conducting the systematic
review
We will conduct the review according to this published protocol
and report any deviations from it in the ’Differences between pro-
tocol and review’ section of the systematic review.
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Measures of treatment effect
We will analyse dichotomous data (e.g. adverse events) as risk ra-
tios or Peto odds ratios when the outcome is a rare event (approx-
imately less than 10%), and use 95% confidence intervals (CIs).
Continuous data (e.g. quality of life, function) will be analysed
as mean difference (MD) or standardised mean difference (SMD,
depending on whether the same scale is used to measure an out-
come, and 95% confidence intervals. We will enter data presented
as a scale with a consistent direction of effect across studies.
When different scales are used to measure the same conceptual
outcome (e.g. function), SMDs will be calculated instead, with
corresponding 95% CI. SMDs will be back-translated to a typical
scale (e.g. 0 to 10 for pain) by multiplying the SMD by a typical
among-person standard deviation (e.g. the standard deviation of
the control group at baseline from themost representative trial) (as
per Chapter 12 of the Cochrane Handbook (Schünemann 2011b).
In the ’Effects of intervention’ results section and the ’Comments’
column of the ’Summary of findings’ table, we will provide the ab-
solute per cent difference, the relative per cent change from base-
line, and the number needed-to-treat for an additional beneficial
outcome (NNTB) or the number needed to treat for an additional
harmful outcome (NNTH) (the NNTB or NNTH will be pro-
vided only when the outcome shows a statistically significant dif-
ference).
For dichotomous outcomes, such as serious adverse events, the
NNTH will be calculated from the control group event rate and
the relative risk using the Visual Rx NNT calculator (Cates 2008).
The NNTB for continuous measures will be calculated using the
Wells calculator (available at the CMSG editorial office http://
musculoskeletal.cochrane.org/).
For dichotomous outcomes, the absolute risk difference will be
calculated using the risk difference statistic in RevMan and the
result expressed as a percentage. For continuous outcomes, the
absolute benefit will be calculated as the improvement in the in-
tervention group minus the improvement in the control group, in
the original units.
The relative per cent change for dichotomous data will be calcu-
lated as the risk ratio - 1 and expressed as a percentage. For contin-
uous outcomes, the relative difference in the change from baseline
will be calculated as the absolute benefit divided by the baseline
mean of the control group from the most representative study.
Unit of analysis issues
Where multiple trial arms are reported in a single trial, we will
include only the relevant intervention arms. If two comparisons
are combined in a three-arm trial , we will halve the control group
to avoid double-counting. Such study characteristics (e.g. more
than two intervention groups in single trials) will be detailed in
the table ’Characteristics of included studies’.
Dealing with missing data
We will contact investigators or study sponsors in order to verify
key study characteristics and obtain missing numerical outcome
data where possible (e.g. when a study is identified as abstract only
orwhendata are not available for all participants).Where this is not
possible, and themissingdata are thought to introduce serious bias,
we will explore the impact of including such studies in the overall
assessment of results by a sensitivity analysis. Any assumptions and
imputations to handle missing data will be clearly described and
the effect of imputation will be explored by sensitivity analyses.
For dichotomous outcomes (e.g. number of withdrawals due to
adverse events), the withdrawal rate will be calculated using the
number of patients randomised in the group as the denominator.
For continuous outcomes (e.g. mean change in pain score), we
will calculate the MD or SMD based on the number of patients
analysed at that time point. If the number of patients analysed
is not presented for each time point, the number of randomised
patients in each group at baseline will be used.
Where possible, missing standard deviations will be computed
from other statistics such as standard errors, CIs or P values, ac-
cording to the methods recommended in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011b). If standard
deviations cannot be calculated, they will be imputed (e.g. from
other studies in the meta-analysis) (Higgins 2011b).
Assessment of heterogeneity
Clinical and methodological diversity will be assessed in terms of
participants, interventions, outcomes and study characteristics for
the included studies to determine whether a meta-analysis is ap-
propriate. This will be determined by observing these data from
the data extraction tables. Statistical heterogeneity will be assessed
by visual inspection of the forest plot to assess for obvious differ-
ences in results between the studies, and using the I² and Chi²
statistical tests.
As recommended in the Cochrane Handbook (Deeks 2011), the
interpretation of an I² value of 0% to 40% might ’not be im-
portant’; 30% to 60% may represent ’moderate’ heterogeneity;
50% to 90% may represent ’substantial’ heterogeneity; and 75%
to 100% represents ’considerable’ heterogeneity. As noted in the
Handbook, we will keep in mind that the importance of I2 de-
pends on (i) magnitude and direction of effects and (ii) strength
of evidence for heterogeneity.
The Chi² test will be interpreted where a P value ≤ 0.10 will
indicate evidence of statistical heterogeneity.
If we identify substantial heterogeneity we will report it and inves-
tigate possible causes by following the recommendations in sec-
tion 9.6 of the Handbook (Deeks 2011).
A meta-regression analysis is not planned as it does not fit into
the objectives of this review. In the event that a meta-analysis is
not feasible, we will present a qualitative and narrative synthesis,
based on the CMSG classification documented previously.
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Assessment of reporting biases
We will create and examine a funnel plot to explore possible small
study biases. In interpreting funnel plots, we will examine the
different possible reasons for funnel plot asymmetry as outlined in
section 10.4 of the Handbook and relate this to the results of the
review. If we are able to pool more than 10 trials, we will undertake
formal statistical tests to investigate funnel plot asymmetry, and
will follow the recommendations in section 10.4 of the Handbook
(Sterne 2011).
To assess outcome reporting bias, we will check trial protocols
against published reports. For studies published after 1 July 2005,
we will screen the Clinical Trial Register at the International Clin-
ical Trials Registry Platform of the World Health Organisation
(http://apps.who.int/trialssearch) for the a priori trial protocol.We
will evaluate whether selective reporting of outcomes is present.
Data synthesis
Wewill undertakemeta-analyses only where this ismeaningful, i.e.
if the treatments, participants and the underlying clinical question
are similar enough for pooling to make sense.
We will present separate pair-wise analyses grouped by common
comparator, for example, all water-based exercise delivered by ex-
ercise professionals versus all water-based exercise delivered by
healthcare professionals.
Due to the nature of exercise as a highly-varied intervention and
the complexity of models of care that may be associated with dif-
ferent delivery modes, substantial heterogeneity and subsequently
difference in underlying treatment effects between trials is envis-
aged. Therefore, we will perform a random-effects meta-analysis
for combining data to produce an overall summary of the aver-
age treatment effect across trials in RevMan. The random-effects
summary will be treated as the average of the range of possible
treatment effects. Also, to check the robustness of the treatment ef-
fects on pain and function, sensitivity analyses using a fixed-effect
analysis will be performed and we will discuss clinical and practice
implications of the difference in treatment effects between trials.
’Summary of findings’ table
We will create a ’Summary of findings’ table using the following
outcomes at the stated primary end points:
• Pain
• Physical function
• Quality of life
• Number of participants experiencing any adverse event
• Number of participants who withdrew
• Number of participants experiencing any serious adverse
events
Two review authors (EH, NW)will independently assess the qual-
ity of the evidence. We will use the five GRADE considerations
(study limitations, consistency of effect, imprecision, indirectness
and publication bias) to assess the quality of a body of evidence
as it relates to the studies which contribute data to the meta-anal-
yses for the prespecified outcomes. We will use methods and rec-
ommendations described in Chapter 11 the Cochrane Handbook
for Systematic Reviews of Interventions (Schünemann 2011a) using
GRADEpro software (GRADEpro GDT 2015). We will justify
all decisions to down- or up-grade the quality of studies using
footnotes and we will make comments to aid the reader’s under-
standing of the review where necessary.
The ’Summary of findings’ table will be informed by the quality
of evidence for treatment effects (as assessed by GRADE) and how
the risks of bias in the primary studies contribute to each outcome.
Hence, the ’Summary of findings’ table will be created after data
from all primary studies have been entered into RevMan (RevMan
2014), and after the ’Risk of bias’ assessment has been conducted.
This will reduce the risk of review bias and enhance the process of
generating more accurate inferences about the review outcomes,
the treatment effect and their confidence estimates for the review.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses:
• Site of joint pain (e.g. hip or knee);
• Group or individual format;
• Gender.
We will use the following outcomes in subgroup analyses:
• Pain;
• Function;
• Quality of life.
If data stratified by symptom duration are not available, but if
there are sufficient continuous data from at least 10 studies, wewill
consider meta-regression to assess if symptom duration modifies
the effect of the intervention on pain and function (using Stata
statistical package STATA 2016).
We will consider presenting the estimate of treatment effects at
two time points for the primary outcomes (pain, function and
quality of life) as subgroups on a single forest plot.
We will use the formal test for subgroup interactions in Review
Manager (RevMan 2014) andwill use caution in the interpretation
of subgroup analyses as advised in section 9.6 of the Handbook
(Deeks 2011). The magnitude of the effects will be compared
between the subgroups by means of assessing the overlap of the
CIs of the summary estimated. Non-overlap of the CIs indicates
statistical significance.
Sensitivity analysis
The primary analysis for subjective self-reported outcomes (pain,
function, quality of life) will be restricted to studies with low
risk of selection and detection biases. We will conduct sensitivity
analyses to investigate the effects of selection and detection biases
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by including trials with low or unclear risk of these biases on the
primary outcomes of pain and function. All studies canbe included
for adverse event outcomes.
Interpreting results and reaching conclusions
We will follow the guidelines in the Cochrane Handbook (
Schünemann 2011b), for interpreting results and will be aware of
distinguishing a lack of evidence of effect from a lack of effect. We
will base our conclusions only on findings from the quantitative
or narrative synthesis of included studies for this review. We will
avoid making recommendations for practice and our implications
for research will suggest priorities for future research and outline
what the remaining uncertainties are in the area.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp Exercise/
2. exp Exercise Therapy/
3. (strength$ or isometric$ or isotonic$ or isokinetic$).ti,ab.
4. (resistance adj3 train$).ti,ab.
5. ((physical$ or motion$) adj3 (fit$ or therap$)).ti,ab.
6. exp Physical Fitness/
7. (treadmill$ or cross-train$ or rowing).ti,ab.
8. sport$.ti,ab.
9. exercise$.ti,ab.
10. (tai adj1 (chi or ji)).ti,ab.
11. (dance or dancer$ or dances or dancing).ti,ab.
12. (aqua$ or water$).ti,ab.
13. hydr$.ti,ab.
14. exp Hydrotherapy/
15. (stretch$ or flexib$ or balanc$ or propriocept$).ti,ab.
16. (circuit$ adj1 train$).ti,ab.
17. exp “physical education and training”/
18. exp recreation/
19. exp Musculoskeletal Physiological Phenomena/
20. “physical activit$”.ti,ab.
21. aerobic$.ti,ab.
22. (run or jog$ or running).ti,ab.
23. (walk or walks or walking).ti,ab.
24. gym$.ti,ab.
25. tai ji/ or yoga/
26. yoga.ti,ab.
27. tai-chi.ti,ab.
28. qigong.ti,ab.
29. pilates.ti,ab.
30. “leisure activit$”.ti,ab.
31. “recreation$ activit$”.ti,ab.
32. (zumba or salsa$).ti,ab.
11Community-based exercise and physical activity programmes led by exercise professionals for osteoarthritis (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
33. (cycling or bicycle or bike).ti,ab.
34. swim$.ti,ab.
35. fitness.ti,ab.
36. (keep$ adj1 (active or fit)).ti,ab.
37. trainer$.mp.
38. instructor$.mp.
39. teacher$.mp.
40. program$.mp.
41. “personal training”.mp.
42. (coaching or coach or coaches).mp.
43. (leisure adj2 centre$).mp.
44. (school$ or village$ or church$ or communit$).mp.
45. “adult education”.mp.
46. or/1-45
47. exp Pain/
48. exp Knee/
49. exp Hand/
50. exp Hip/
51. or/48-50
52. 47 and 51
53. (pain$ adj2 joint$).ti,ab.
54. (pain$ adj2 musculoskeletal).ti,ab.
55. (degenerative adj2 (joint$ or arthr$)).ti,ab.
56. (pain$ adj2 (patell$ or knee$)).ti,ab.
57. (pain$ adj2 (thumb$ or hand$)).ti,ab.
58. (pain$ adj2 hip$).ti,ab.
59. exp osteoarthritis/
60. (osteoarthr$ or arthros?s).ti,ab.
61. or/52-60
62. randomized controlled trial.pt.
63. controlled clinical trial.pt.
64. placebo.ab.
65. randomly.ab.
66. clinical trials as topic.sh.
67. trial.ti.
68. randomi#ed.ab.
69. or/62-68
70. exp animals/ not humans.sh.
71. 69 not 70
72. 46 and 61 and 71
C O N T R I B U T I O N S O F A U T H O R S
Task Authors
Draft the protocol Walsh, Healey, Babatunde, Powell, Jordan
Develop a search strategy Jordan (with search terms from Walsh, Healey, Babatunde)
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